White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities

White matter hyperintensities (WMHs) are frequently seen on brain magnetic resonance imaging scans of older people. Usually interpreted clinically as a surrogate for cerebral small vessel disease, WMHs are associated with increased likelihood of cognitive impairment and dementia (including Alzheimer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer's & dementia : translational research & clinical interventions 2019, Vol.5 (1), p.107-117
Hauptverfasser: Alber, Jessica, Alladi, Suvarna, Bae, Hee-Joon, Barton, David A., Beckett, Laurel A., Bell, Joanne M., Berman, Sara E., Biessels, Geert Jan, Black, Sandra E., Bos, Isabelle, Bowman, Gene L., Brai, Emanuele, Brickman, Adam M., Callahan, Brandy L., Corriveau, Roderick A., Fossati, Silvia, Gottesman, Rebecca F., Gustafson, Deborah R., Hachinski, Vladimir, Hayden, Kathleen M., Helman, Alex M., Hughes, Timothy M., Isaacs, Jeremy D., Jefferson, Angela L., Johnson, Sterling C., Kapasi, Alifiya, Kern, Silke, Kwon, Jay C., Kukolja, Juraj, Lee, Athene, Lockhart, Samuel N., Murray, Anne, Osborn, Katie E., Power, Melinda C., Price, Brittani R., Rhodius-Meester, Hanneke F.M., Rondeau, Jacqueline A., Rosen, Allyson C., Rosene, Douglas L., Schneider, Julie A., Scholtzova, Henrieta, Shaaban, C. Elizabeth, Silva, Narlon C.B.S., Snyder, Heather M., Swardfager, Walter, Troen, Aron M., van Veluw, Susanne J., Vemuri, Prashanthi, Wallin, Anders, Wellington, Cheryl, Wilcock, Donna M., Xie, Sharon Xiangwen, Hainsworth, Atticus H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:White matter hyperintensities (WMHs) are frequently seen on brain magnetic resonance imaging scans of older people. Usually interpreted clinically as a surrogate for cerebral small vessel disease, WMHs are associated with increased likelihood of cognitive impairment and dementia (including Alzheimer's disease [AD]). WMHs are also seen in cognitively healthy people. In this collaboration of academic, clinical, and pharmaceutical industry perspectives, we identify outstanding questions about WMHs and their relation to cognition, dementia, and AD. What molecular and cellular changes underlie WMHs? What are the neuropathological correlates of WMHs? To what extent are demyelination and inflammation present? Is it helpful to subdivide into periventricular and subcortical WMHs? What do WMHs signify in people diagnosed with AD? What are the risk factors for developing WMHs? What preventive and therapeutic strategies target WMHs? Answering these questions will improve prevention and treatment of WMHs and dementia.
ISSN:2352-8737
2352-8737
DOI:10.1016/j.trci.2019.02.001